Japan has approved two stem cell-based therapies for treating Parkinson's disease and heart failure in a world first, through ...

Personalized therapies for diabetes, while showing promise in international studies, is met with healthy skepticism from ...

According to a team of researchers at Baylor College of Medicine, Tongji University and collaborating institutions, weaning ...

Researchers in Japan pioneered reprogrammed cells 20 years ago. Now the country has given the first-ever authorizations to manufacture and sell medical products based on the technology.

An innovative stem cell therapy approved for severe heart failure has been cleared for use in Japan. Here is why it matters ...

India, March 18 -- Stem cell therapies using induced pluripotent stem cells have received conditional approval in Japan for treating Parkinson's disease and severe heart failure, advancing ...

Aspen Neuroscience’s autologous, personalised stem cell therapy is set for a pivotal trial after it showed improved "ON" and ...

The first cell rejuvenation therapy is set to enter clinics, testing if aging cells can be reset to a younger, healthier ...

Japan’s health ministry has endorsed two stem-cell therapies derived from induced pluripotent stem (iPS) cells, making them the first treatments of their kind to clear a national regulatory body ...

Silicon nanotube arrays deliver functional mRNA into human pluripotent stem cells for the first time, achieving up to 64% transfection without compromising stem cell identity.

The International Society for Stem Cell Research (ISSCR) is pleased to announce that Alexander Meissner, Director at the Max Planck Institute for Molecular Genetics, Germany, has been named the ...

Japan has approved the world’s first stem cell therapy for Parkinson’s disease, offering new hope for millions globally. The treatment uses induced pluripotent stem (iPS) cells to replace damaged ...